Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Anti Allergy Agents

Volume 2

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2452-3194 (Print)
ISSN: 2214-6938 (Online)
ISBN: 978-1-68108-160-1 (Print)
ISBN: 978-1-68108-159-5 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810815951160201


Frontiers in Clinical Drug Research - Anti-Allergy Agents is an exciting eBook series comprising a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.

The second volume of this series brings 7 reviews which cover neuro- and immunomodulating therapies for asthma and COPD, antioxidant therapies for allergies, allergic rhinitis medications and more.

Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.


The second volume of Frontiers in Clinical Drug Research – Anti Allergy Agents comprises seven comprehensive chapters covering various aspects of clinical drugs used for treating the allergic conditions contributed by leading researchers in the field.

In the first chapter, Vermeulen and colleagues focus mainly on the commonly occurring pulmonary tract ailments. They discuss the inflammatory mediators and neuromodulators that play a significant role in these diseases. They have provided a comprehensive overview of the novel therapeutic targets; histamine, acetylcholine and cysteinyl-leukotrienes, with emphasis on the advantages and shortcomings of the clinical trials carried out. In the second chapter, Zuo et al. discuss the various antioxidants available from supplements and diet that are potentially useful for the treatment and prevention of asthma. The pathogenesis of allergic asthma and its correlation with inflammation and ROS/OS are presented. In chapter 3, Higuera-de la Tijera and Servín- Caamaño highlight the role of anti-oxidants in managing the inflammatory liver diseases with a metabolic origin, for minimizing the oxidative stress.

Cingi and colleagues review the management therapies for allergic rhinitis in chapter 4. The different pharmacological therapies and recent advancements in the field of Allergic Rhinitis (AR) are presented including the treatment of pediatric AR patients. In chapter 5, Suphiglu and Ahmed present a comprehensive overview on Th2 cytokines as the new therapeutic target for the development of anti-allergic agents. They have highlighted the important targets, cytokines IL-4 and IL-13 and their receptors, that are key factors in the allergic cascade.

Nakagawa et al., in chapter 6 present the role of algogenic substances (chemicals and natural products), their receptors, and anti-inflammatory drugs interrupting receptors, channels, and intracellular messengers, mainly in peripheral sensitization. They also discuss thermosensing TRP channels and IL-1β. TRP channels are closely correlated with itching and inflammation. In the final chapter of this eBook, Hassoba and colleagues present a comprehensive overview on allergic disorders and anti-allergy agents from almost all aspects in light of various contributions.

I would like to thank all the contributors for their painstaking efforts in putting together an outstanding collections of reviews that comprehensively cover various aspects of this important field. I am also grateful to the excellent team of Bentham Science Publishers, especially Dr. Faryal Sami and Mr. Shehzad Naqvi led by Mr. Mahmood Alam, Director Bentham Science Publishers.

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge